Harbor Investment Advisory’s Arbutus Biopharma ABUS Stock Holding History

Harbor Investment Advisory’s Portfolio ABUS Stock Details ABUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.4K	Hold	500	–	–	﹤0.01%	1188
2026 Q1	$2.25K	Hold	500	–	–	﹤0.01%	1102
2025 Q4	$2.4K	Hold	500	–	–	﹤0.01%	1126
2025 Q3	$2.27K	Hold	500	–	–	﹤0.01%	1092
2025 Q2	$1.54K	Hold	500	–	–	﹤0.01%	1100
2025 Q1	$1.75K	Hold	500	–	–	﹤0.01%	1088
2024 Q4	$1.64K	Hold	500	–	–	﹤0.01%	1076
2024 Q3	$1.93K	Sell	500 -303	-38%	-$1.16K	﹤0.01%	1072
2024 Q2	$2.48K	Hold	803	–	–	﹤0.01%	1047
2024 Q1	$2.07K	Hold	803	–	–	﹤0.01%	1102
2023 Q4	$2.01K	Hold	803	–	–	﹤0.01%	1049
2023 Q3	$1.63K	Hold	803	–	–	﹤0.01%	1065
2023 Q2	$1.85K	Hold	803	–	–	﹤0.01%	1222
2023 Q1	$2.43K	Buy	803 +303	+61%	+$855	﹤0.01%	1201
2022 Q4	$1.17K	Hold	500	–	–	﹤0.01%	1240
2022 Q3	$1K	Hold	500	–	–	﹤0.01%	1256
2022 Q2	$1K	Hold	500	–	–	﹤0.01%	1274
2022 Q1	$1K	Hold	500	–	–	﹤0.01%	1280
2021 Q4	$2K	Hold	500	–	–	﹤0.01%	1208
2021 Q3	$2K	Hold	500	–	–	﹤0.01%	1218
2021 Q2	$2K	Hold	500	–	–	﹤0.01%	1160
2021 Q1	$2K	Hold	500	–	–	﹤0.01%	1145
2020 Q4	$2K	Hold	500	–	–	﹤0.01%	1081
2020 Q3	$2K	Sell	500 -500	-50%	-$1.52K	﹤0.01%	1007
2020 Q2	$2K	Hold	1,000	–	–	﹤0.01%	966
2020 Q1	$1K	Hold	1,000	–	–	﹤0.01%	956
2019 Q4	$3K	Buy	+1,000	New	+$1.62K	﹤0.01%	740

Other funds holding ABUS

FCH

Freestone Capital Holdings Seattle, Washington $3.86B AUM 26.3% 1-Year Est. Return

LWA

Ledgewood Wealth Advisors Exeter, New Hampshire $188M AUM 18.45% 1-Year Est. Return

STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

WMA

Wealth Management Associates Cherry Hill, New Jersey $362M AUM 33.28% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

PPWP

Premier Path Wealth Partners Madison, New Jersey $870M AUM 30% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

AHL

Abel Hall LLC Baton Rouge, Louisiana $579M AUM 54.21% 1-Year Est. Return

Harbor Investment Advisory's ABUS Position: Q2 2026 in Review

Harbor Investment Advisory held its Arbutus Biopharma (ABUS) position steady in Q2 2026 at 500 shares worth $2.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1188.

Harbor Investment Advisory first reported a position in ABUS in Q4 2019 and has held it in 27 quarters since. The position peaked at $3K in Q4 2019. 25 funds tracked by Wall St. Rank hold ABUS as of Q2 2026.

Harbor Investment Advisory held 500 shares of Arbutus Biopharma worth $2.4K as of Q2 2026.
Harbor Investment Advisory left its Arbutus Biopharma share count unchanged in Q2 2026.
Arbutus Biopharma made up ﹤0.01% of Harbor Investment Advisory's portfolio in Q2 2026, its #1188 holding.
Harbor Investment Advisory first reported a position in Arbutus Biopharma in Q4 2019 and has held it in 27 quarters since.
Harbor Investment Advisory's Arbutus Biopharma position peaked at $3K in Q4 2019.
25 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q2 2026.

Based on Harbor Investment Advisory's 13F filing for Q2 2026, filed 7 Jul 2026.